| Market Cap | ₹1,02,595Cr |
| ROE | 16.03% |
| P/E Ratio(TTM) | 17.88 |
| EPS(TTM) | 68.75 |
| P/B Ratio | 2.85 |
| Dividend Yield | 0.65% |
| Industry P/E | 33.47 |
| Book Value | 431.50 |
| Debt to Equity | 0.16 |
| Face Value | 1 |
| Parent Organisation | Dr.reddy's Laboratories Ltd |
| Managing Director | Mr. Gunupati Prasad |
| NSE Symbol | DRREDDY |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | NA (0.00%) | 39.63 | ||
| Cipla | NA (0.00%) | 22.59 | ||
| Zydus Lifesciences | NA (0.00%) | 19.03 | ||
| Mankind Pharma | NA (0.00%) | 52.89 |